Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697347 | SCV000715516 | likely benign | not provided | 2018-06-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000878909 | SCV001021900 | likely benign | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000878909 | SCV004236321 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2023-07-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001697347 | SCV005225667 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003962750 | SCV004778029 | benign | MCCC2-related disorder | 2023-11-22 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |